Mihaela Manole
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mihaela Manole has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Antoneta Dacia Petroaie
“Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
5 shared publications - Adorata Elena Coman
“Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania
4 shared publications - Agnes Bacusca
“Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
4 shared publications - Ana Maria Slanina
“Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
4 shared publications - Carmen Liliana Barbacariu
“Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
3 shared publications - Dana-Teodora Anton-Păduraru
Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
3 shared publications
Latest Publications
- Open Access
- 7 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8706
From Risk Markers to Preventive Action: A Proposed Semi-Quantitative Clinical Actionability Framework for Cardiometabolic Precision Prevention in Primary Care—A Narrative Review
Cardiometabolic prevention in primary care draws on a growing number of risk markers, yet a marker’s capacity to predict risk is often conflated with its capacity to change management. This narrative review proposes a semi-quantitative clinical actionability framework that takes the marker–context–action use case as its unit of appraisal and assigns ordinal scores (0–3) to seven domains: measurement readiness, prognostic validity, decision-relevant information, therapeutic linkage, clinical-utility evidence, harms and burden, and transportability and equity. Gating rules prevent prognostic strength alone from determining the tier. Applied by the authors to 19 use cases, the framework provisionally assigned five to Tier A (routine actionability): low-density lipoprotein cholesterol, blood pressure, type 2 diabetes detection, kidney function with albuminuria in diabetes or hypertension, and familial hypercholesterolaemia case-finding. Nine were assigned to Tier B (selective actionability), including the coronary artery calcium, apolipoprotein B, lipoprotein(a), natriuretic peptide and ankle–brachial index use cases, three to Tier C and two to Tier D. Most assignments depended on one-point differences in therapeutic linkage or clinical-utility scores. Tiers describe evaluated use cases, not intrinsic marker properties; the framework has not been validated. It implies that closing implementation gaps in Tier A use cases should generally precede the introduction of newer markers.
- 7 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8706
Open AccessFrom Risk Markers to Preventive Action: A Proposed Semi-Quantitative Clinical Actionability Framework for Cardiometabolic Precision Prevention in Primary Care—A Narrative Review
Cardiometabolic prevention in primary care draws on a growing number of risk markers, yet a marker’s capacity to predict risk is often conflated with its capacity to change management. This narrative review proposes a semi-quantitative clinical actionability framework that takes the marker–context–action use case as its unit of appraisal and assigns ordinal scores (0–3) to seven domains: measurement readiness, prognostic validity, decision-relevant information, therapeutic linkage, clinical-utility evidence, harms and burden, and transportability and equity. Gating rules prevent prognostic strength alone from determining the tier. Applied by the authors to 19 use cases, the framework provisionally assigned five to Tier A (routine actionability): low-density lipoprotein cholesterol, blood pressure, type 2 diabetes detection, kidney function with albuminuria in diabetes or hypertension, and familial hypercholesterolaemia case-finding. Nine were assigned to Tier B (selective actionability), including the coronary artery calcium, apolipoprotein B, lipoprotein(a), natriuretic peptide and ankle–brachial index use cases, three to Tier C and two to Tier D. Most assignments depended on one-point differences in therapeutic linkage or clinical-utility scores. Tiers describe evaluated use cases, not intrinsic marker properties; the framework has not been validated. It implies that closing implementation gaps in Tier A use cases should generally precede the introduction of newer markers.
- Open Access
- 27 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3635
Correlates of Health Satisfaction in a Web-Based Sample Enriched for Self-Reported Polycystic Ovary Syndrome: An Exploratory Cross-Sectional Study
Background/Objectives: Polycystic ovary syndrome (PCOS), named polyendocrine metabolic ovarian syndrome by a 2026 global consensus, combines metabolic, dermatological and psychological features. We examined which clinical, anthropometric and symptom-related characteristics were associated with health satisfaction in a web-based sample enriched for self-reported PCOS. Methods: Cross-sectional web-based survey using a Romanian-language questionnaire (October–November 2023). Of 212 submissions retained after integrity screening, 159 (75.0%) reported a previous diagnosis of PCOS. Health satisfaction (study-specific five-point item) was analysed with proportional-odds ordinal regression including seven covariates, irrespective of diagnostic status (n = 194). Sensitivity analyses restricted the model to respondents reporting a diagnosis, adjusted for diagnostic status or sociodemographic characteristics and retained all submissions. Results: Lower health satisfaction was associated with higher body mass index (OR 0.92 per kg/m2; 95% CI 0.87–0.97), self-reported hirsutism (OR 0.43; 95% CI 0.24–0.76) and reported anxiety (OR 0.49; 95% CI 0.28–0.87; reference group mostly “do not know/no answer”). Estimates changed little after these adjustments or with all submissions; among respondents reporting a diagnosis (n = 145), the estimates for self-reported hirsutism and reported anxiety were attenuated and imprecise. Age, menstrual irregularity, infertility diagnosis and dysmenorrhea severity showed no statistically detectable association. Conclusions: These exploratory, mutually adjusted associations involve higher body mass index, self-reported hirsutism and endorsement of the questionnaire’s anxiety option; the last reflects a response contrast, not clinically assessed anxiety. They warrant confirmation in clinically characterised cohorts using validated instruments.
- 27 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3635
Open AccessCorrelates of Health Satisfaction in a Web-Based Sample Enriched for Self-Reported Polycystic Ovary Syndrome: An Exploratory Cross-Sectional Study
Background/Objectives: Polycystic ovary syndrome (PCOS), named polyendocrine metabolic ovarian syndrome by a 2026 global consensus, combines metabolic, dermatological and psychological features. We examined which clinical, anthropometric and symptom-related characteristics were associated with health satisfaction in a web-based sample enriched for self-reported PCOS. Methods: Cross-sectional web-based survey using a Romanian-language questionnaire (October–November 2023). Of 212 submissions retained after integrity screening, 159 (75.0%) reported a previous diagnosis of PCOS. Health satisfaction (study-specific five-point item) was analysed with proportional-odds ordinal regression including seven covariates, irrespective of diagnostic status (n = 194). Sensitivity analyses restricted the model to respondents reporting a diagnosis, adjusted for diagnostic status or sociodemographic characteristics and retained all submissions. Results: Lower health satisfaction was associated with higher body mass index (OR 0.92 per kg/m2; 95% CI 0.87–0.97), self-reported hirsutism (OR 0.43; 95% CI 0.24–0.76) and reported anxiety (OR 0.49; 95% CI 0.28–0.87; reference group mostly “do not know/no answer”). Estimates changed little after these adjustments or with all submissions; among respondents reporting a diagnosis (n = 145), the estimates for self-reported hirsutism and reported anxiety were attenuated and imprecise. Age, menstrual irregularity, infertility diagnosis and dysmenorrhea severity showed no statistically detectable association. Conclusions: These exploratory, mutually adjusted associations involve higher body mass index, self-reported hirsutism and endorsement of the questionnaire’s anxiety option; the last reflects a response contrast, not clinically assessed anxiety. They warrant confirmation in clinically characterised cohorts using validated instruments.
- Open Access
Unraveling Metabolic Syndrome in Youth: The Obesity Epidemic’s Hidden Complication
Background/Objectives: One of the metabolic complications of obesity is known as Metabolic Syndrome (MetS). This narrative review aims to synthesize current research on MetS in young populations, identify knowledge gaps, and guide future studies and funding priorities. It provides evidence-based insights into screening, diagnosis, and treatment, offering practical guidance for healthcare professionals. Methods: A comprehensive search of the literature was conducted to identify relevant studies on obesity in MetS in PubMed and Google Academic electronic database. The search was performed using a combination of “obesity”, “complications”, “metabolic syndrome”, “children”, and “adolescents” keywords. Studies were selected based on predefined inclusion and exclusion criteria to ensure relevance and methodological rigor. Results: The lack of universally accepted diagnostic criteria for MetS in children has led to inconsistencies in its definition across medical literature. Irrespective of the chosen diagnostic approach, the prevalence of MetS in children and adolescents has exhibited a concurrent rise with the increasing rates of obesity in this age group. The pathophysiology of MetS remains incompletely understood, with ongoing discussions on the interplay of genetic, epigenetic, environmental, dietary, and lifestyle factors. Screening for MetS is recommended for overweight and obese children. Conclusions: Establishing global, consensus-driven criteria that account for ethnicity, gender, and age would enhance diagnostic accuracy and treatment approaches. The prevention of excessive weight among children and adolescents stands as a paramount objective within modern society’s healthcare system. Considering the complexity of the disease and the treatment, the team must be multidisciplinary.
Open AccessUnraveling Metabolic Syndrome in Youth: The Obesity Epidemic’s Hidden Complication
Background/Objectives: One of the metabolic complications of obesity is known as Metabolic Syndrome (MetS). This narrative review aims to synthesize current research on MetS in young populations, identify knowledge gaps, and guide future studies and funding priorities. It provides evidence-based insights into screening, diagnosis, and treatment, offering practical guidance for healthcare professionals. Methods: A comprehensive search of the literature was conducted to identify relevant studies on obesity in MetS in PubMed and Google Academic electronic database. The search was performed using a combination of “obesity”, “complications”, “metabolic syndrome”, “children”, and “adolescents” keywords. Studies were selected based on predefined inclusion and exclusion criteria to ensure relevance and methodological rigor. Results: The lack of universally accepted diagnostic criteria for MetS in children has led to inconsistencies in its definition across medical literature. Irrespective of the chosen diagnostic approach, the prevalence of MetS in children and adolescents has exhibited a concurrent rise with the increasing rates of obesity in this age group. The pathophysiology of MetS remains incompletely understood, with ongoing discussions on the interplay of genetic, epigenetic, environmental, dietary, and lifestyle factors. Screening for MetS is recommended for overweight and obese children. Conclusions: Establishing global, consensus-driven criteria that account for ethnicity, gender, and age would enhance diagnostic accuracy and treatment approaches. The prevention of excessive weight among children and adolescents stands as a paramount objective within modern society’s healthcare system. Considering the complexity of the disease and the treatment, the team must be multidisciplinary.
- Open Access
- 9 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31331
The Effects of the COVID-19 Pandemic on Mental Health: A Web-Based Study Among Romanian Adults
In Romania, as in other parts of the world, the family doctor is the first to make contact with a healthy patient and is also the first to notice even the smallest pathological changes. In the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the patient's communication with the family doctor became even closer and some behavioral changes could be easily noticed. To assess the symptoms of anxiety and depression in the Romanian population using social media platforms in the context of the COVID-19 pandemic. We conducted an anonymous, web-based cross-sectional survey consisting of 31 questions related to general characteristics (age, gender, education, inhabitancy, residence, smoking status, and alcohol consumption) and adapted GAD-7 (7-item General Anxiety Disorders questionnaire) and PHQ-9 (9-item Patient Health Questionnaire). This questionnaire was sent to volunteers in an electronic format through a social network (Facebook, Twitter). The data collected were statistically processed using IBM SPSS v25.0 (IBM Corp., Armonk, NY). The inclusion criteria were age over 18 years and no history of chronic disease. The exclusion criteria consisted of the absence of a mental illness diagnosis. From the 1254 respondents, 1232 cases were selected for statistical analysis after applying the exclusion criteria. The mean age was 35.94 (SD = 11.4, 95%CI=10.9-11.9) with a minimum of 18 years and a maximum of 97 years. Eighty-four point nine percent (84.9%; N=1046) of all study participants are female and 79.13% (N= 975) live in the urban area. A total of 188 (15.25%) were diagnosed with COVID-19 of which 31 (16.66%) were male and 157 (15%) were female. N=170 (13.8%) reported moderate symptoms of anxiety during the last two weeks before the survey while N=96 (7.8%) had severe anxiety. Twenty-two point two percent (22.2%; N=274) of the participants reported moderate symptoms of depression while 10.1% (N=125) had moderately severe symptoms and 6.6% (N=81) could be diagnosed with severe depression. A greater likelihood of screening for depression diagnosis was associated with ages between 25 and 34 years (OR=0.90, 95%CI=0.86-0.94, P<.001), 35 and 44 years (OR=0.88, 95%CI=0.84-0.93, P<.001), and 45 and 54 years (OR=0.87, 95%CI=0.82-0.92, P<.001). Also, a tendency was observed for women to be more prone to high levels of anxiety (OR=1.21, 95%CI=1.08-1.35, P< .001) and depression (OR=2.16, 95%CI=1.51-308, P< .005). Regarding the high prevalence of depression and anxiety, especially in women, appropriate measures for the risk categories should be applied. In the new social context created by the COVID-19 pandemic, screening for psychiatric and psychological disorders should be performed by telemedicine.
- 9 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31331
Open AccessThe Effects of the COVID-19 Pandemic on Mental Health: A Web-Based Study Among Romanian Adults
In Romania, as in other parts of the world, the family doctor is the first to make contact with a healthy patient and is also the first to notice even the smallest pathological changes. In the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the patient's communication with the family doctor became even closer and some behavioral changes could be easily noticed. To assess the symptoms of anxiety and depression in the Romanian population using social media platforms in the context of the COVID-19 pandemic. We conducted an anonymous, web-based cross-sectional survey consisting of 31 questions related to general characteristics (age, gender, education, inhabitancy, residence, smoking status, and alcohol consumption) and adapted GAD-7 (7-item General Anxiety Disorders questionnaire) and PHQ-9 (9-item Patient Health Questionnaire). This questionnaire was sent to volunteers in an electronic format through a social network (Facebook, Twitter). The data collected were statistically processed using IBM SPSS v25.0 (IBM Corp., Armonk, NY). The inclusion criteria were age over 18 years and no history of chronic disease. The exclusion criteria consisted of the absence of a mental illness diagnosis. From the 1254 respondents, 1232 cases were selected for statistical analysis after applying the exclusion criteria. The mean age was 35.94 (SD = 11.4, 95%CI=10.9-11.9) with a minimum of 18 years and a maximum of 97 years. Eighty-four point nine percent (84.9%; N=1046) of all study participants are female and 79.13% (N= 975) live in the urban area. A total of 188 (15.25%) were diagnosed with COVID-19 of which 31 (16.66%) were male and 157 (15%) were female. N=170 (13.8%) reported moderate symptoms of anxiety during the last two weeks before the survey while N=96 (7.8%) had severe anxiety. Twenty-two point two percent (22.2%; N=274) of the participants reported moderate symptoms of depression while 10.1% (N=125) had moderately severe symptoms and 6.6% (N=81) could be diagnosed with severe depression. A greater likelihood of screening for depression diagnosis was associated with ages between 25 and 34 years (OR=0.90, 95%CI=0.86-0.94, P<.001), 35 and 44 years (OR=0.88, 95%CI=0.84-0.93, P<.001), and 45 and 54 years (OR=0.87, 95%CI=0.82-0.92, P<.001). Also, a tendency was observed for women to be more prone to high levels of anxiety (OR=1.21, 95%CI=1.08-1.35, P< .001) and depression (OR=2.16, 95%CI=1.51-308, P< .005). Regarding the high prevalence of depression and anxiety, especially in women, appropriate measures for the risk categories should be applied. In the new social context created by the COVID-19 pandemic, screening for psychiatric and psychological disorders should be performed by telemedicine.
- Open Access
- 18 December 2020
- Published by Springer Nature
The effects of the COVID-19 pandemic on mental health
- 18 December 2020
- Published by Springer Nature
Open AccessThe effects of the COVID-19 pandemic on mental health